伝統医薬データベース　

サイト内検索結果「」

全16,951件中、3,361件～3,380件を表示しています。
[1] ・・・ [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] ・・・ [848]

6721. [生薬成分の代謝] 代謝パラメータ『Intravenous administration』

Intravenous administration 5 mg/kg 1.81 ± 0.45 mg/ml 3.34 ± 0.38 min^-1 12.4 ± 1.6 min 0.0065 ± 0.0015 mg/ml 0.092 ± 0.002 min^-1 451.0 ± 98.2 min 2.75 ± 0.69 l/kg 12.37 ± 2.21 l/kg 152.43 ± 23.07

6722. [生薬成分の代謝] 代謝物『3-(4-hydroxy-3,5-dimethoxyphenyl)propanoic acid』

3-(4-hydroxy-3,5-dimethoxyphenyl)propanoic acid 3-(4-hydroxy-3,5-dimethoxyphenyl)propanoic acid C11H14O5 226.229 226.0841 227.092 225.0763 Sinapic acid 代謝物

6723. [生薬成分の代謝] 代謝パラメータ『Oral administration』

Oral administration 40 mg/kg 2.57 ± 1.1 h ^a 110.9 ± 32.1 ng∙h∙ml^-1 ^a 0-limit 4.06 ± 1.7 h ^a 0.78 ± 0.3 h a p< 0.05, b p< 0.01 compared with conventional rats; Data are expressed as m

6724. [生薬成分の代謝] 代謝物『Ginsenoside Rd』

(2S,3S,5R,6S)-2-(((3R,5S,6R)-4,5-dihydroxy-2-(((3S,8R,10R,12R,13R,14R)-12-hydroxy-4,4,8,10,14-pentamethyl-17-((2S)-6-methyl-2-(((2R,3R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl

6725. [生薬成分の代謝] 代謝パラメータ『Oral administration』

Oral administration 40 mg/kg 8.66 ± 3.3 h 397.0 ± 67.4 ng∙h∙ml^-1 0-limit 10.33 ± 3.1 h 1.69 ± 1.1 h a p< 0.05, b p< 0.01 compared with conventional rats; Data are expressed as means±S.D

6726. [生薬成分の代謝] 代謝パラメータ『Oral administration』

Oral administration 40 mg/kg 8.57 ± 3.9 h 655.9 ± 204.3 ng∙h∙ml^-1 ^a 0-limit 15.20 ± 4.8 h ^a 6.76 ± 2.4 h a p< 0.05, b p< 0.01 compared with conventional rats; Data are expressed as me

6727. [生薬成分の代謝] 代謝パラメータ『Oral administration』

Oral administration 50 mg/kg 360 min 65.6 ± 8.72 pmol/ml 22260 pmol・min/ml 0-10 h Saikosaponin 代謝パラメータ

6728. [生薬成分の代謝] 代謝物『Aloe-emodin anthrone』

1,8-dihydroxy-3-(hydroxymethyl)anthracen-9(10H)-one Aloe-emodin anthrone 6247-99-0 C15H12O4 256.258 256.0736 257.0814 255.0657 Barbaloin 代謝物

6729. [生薬成分の代謝] 代謝パラメータ『Oral administration』

Oral administration 50 mg/kg 240 min 59.4 ± 5.72 pmol/ml 17424 pmol・min/ml 0-10 h Saikosaponin 代謝パラメータ

6730. [生薬成分の代謝] 代謝パラメータ『Oral administration 』

Oral administration 50 mg/kg 240 min 59.4 ± 5.72 pmol/ml 17424 pmol・min/ml 0-10 h Saikosaponin b1 代謝パラメータ

6731. [生薬成分の代謝] 代謝パラメータ『Oral administration 』

Oral administration 50 mg/kg 30 min 100 ± 14.0 pmol/ml 8652 pmol・min/ml 0-10 h Saikosaponin b1 代謝パラメータ

6732. [生薬成分の代謝] 代謝パラメータ『Intravenous administration』

Intravenous administration 100 mg/kg (n=8) 50.7 ± 33.2 16.9 ± 5.3 min 83.4  26.5* ng/mL 6.60 ± 3.29 μg・min/mL Ae0-24h 0.026 ± 0.013 % of dose GI24h 0.28 ± 0.07 % of dose F 0.5 % * The v

6733. [生薬成分の代謝] 代謝物『Sinapic acid』

3-(4-hydroxy-3,5-dimethoxyphenyl)acrylic acid Sinapic acid 530-59-6 C11H12O5 224.213 224.0685 225.0763 223.0607 Sinapic acid 代謝物

6734. [生薬成分の代謝] 代謝パラメータ『Oral administration 』

Oral administration 50 mg/kg 360 min 65.6 ± 8.72 pmol/ml 22260 pmol・min/ml 0-10 h Saikosaponin b1 代謝パラメータ

6735. [生薬成分の代謝] 代謝マップ『Genistein』

Genistein 腸内細菌 strain PUE Genistein,5-Hydroxyequol A bacterial suspension (50 ml) of strain DZE was inoculated to 0.8 l GAM broth containing genistein (50 mg) and incubated at 37 °C in an anaerobic

6736. [生薬成分の代謝] 代謝マップ『Ephedrine』

Ephedrine (-)-Ephedrine,Norephedrine,4-((1R,2S)-1-hydroxy-2-(methylamino)propyl)phenol,α-Hydroxypropiophenone,4-Hydroxynorephedrine,4-hydroxybenzoic acid,2-(4-hydroxybenzamido)acetic acid,(1R)-1-phen

6737. [生薬成分の代謝] 代謝物『Ginsenoside Rb 1』

(2S,3S,5R,6S)-2-(((2S,3R,5S,6R)-4,5-dihydroxy-2-(((3S,8R,10R,12R,13R,14R)-12-hydroxy-4,4,8,10,14-pentamethyl-17-((2S)-6-methyl-2-(((2S,3R,5S,6S)-3,4,5-trihydroxy-6-(hydroxy((3R,5S,6R)-3,4,5-trihydroxy

6738. [生薬成分の代謝] 代謝物『Phorbol』

(1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-4a,7b,9,9a-tetrahydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-1b,4,4a,7a,7b,8,9,9a-octahydro-1H-cyclopropa[3,4]benzo[1,2-e]azulen-5(1aH)-one Phorbol 17673-25-5 C20H28O6

6739. [生薬成分の代謝] 代謝パラメータ『Oral administration』

Oral administration 2g 1.79 0.99 h 1.03 ± 0.41 h CL/F 1.77 ± 0.84 L h-1 kg-1 0.26 ± 0.13 μg/mL 0.43 ± 0.26 μg h/mL 0-t 1.77 0.34 h (0−∞) 6-Gingerol 代謝パラメータ

6740. [生薬成分の代謝] 代謝物『α-Tocopherol』

(R)-2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-ol α-Tocopherol 59-02-9 C29H50O2 430.715 430.3811 431.3889 429.3733 α-Tocopherol 代謝物

[1] ・・・ [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] ・・・ [848]
全16,951件中、3,361件～3,380件を表示しています。

ページの上へ戻る

TOPICS

生薬

漢方

試験薬物

遺伝子解析情報

化学分析情報

活性試験情報

生薬成分の代謝情報

探索研究